News

To better understand amyotrophic lateral sclerosis (ALS), a research team at Johns Hopkins Medicine was able to transform skin cells from ALS and Lou Gehrig’s disease patients into brain cells affected by this severe condition. The researchers deposited the human-made cells derived from the study into the first…

Researchers at Tel Aviv Medical Center, Tel Aviv University and Rabin Medical Center in Israel discovered a possible link between amyotrophic lateral sclerosis (ALS) and sensitivity to gluten. The study was recently published in the journal JAMA Neurology and is entitled “…

Researchers at the University Medical Center of the Johannes Gutenberg-University, Mainz, Germany recently revealed in the journal Scientific Reports the finding that low-frequency magnetic fields do not have a detrimental effect or aggravate the development of neurodegenerative diseases such as ALS in mice. The study…

Researchers from the Institute of Pathobiochemistry at the Medical Center of Johannes Gutenberg University Mainz, Germany, have recently released results from a study in which they used animal experiments to assess the possibility that low-frequency alternating magnetic fields (LFMF), such as those generated by overhead power lines, are a…

It makes sense that when healthcare providers work together, better outcomes can result for people with amyotrophic lateral sclerosis (ALS). A new study supports this idea by showing that coordinated networks of care for ALS can result in fewer trips to the hospital, less deterioration and an expanded lifespan. The study, titled…

Patients who suffer from amyotrophic lateral sclerosis (ALS) are joining efforts in new ways to support the approval of legislation known as the “Right to Try” law. After a series of online forums and petitions, an ALS patient was granted an audience at Capitol Hill to read a letter about…

This week, Kadimastem, an innovative Israeli biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell (hPSC)-based therapeutic solutions for the neurodegenerative diseases Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS), announced that it plans to begin human trials using its stem-cell technology to…

A study published in the latest edition of Nature Immunology presents evidence that a key protein associated with Amyotrophic lateral sclerosis (ALS) also plays an important role in a patient’s immune response to viral infections.  The study entitled, “Senataxin suppresses the antiviral transcriptional…

In a recent study titled “Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis,” published in the journal Nature Immunology, researchers at Mount Sinai Hospital/Mount Sinai School of Medicine found that a human protein called senataxin (SETX), which has been found to…

Changes in a house-keeping gene that cleans up damaged proteins from cells may be in part to blame for Lou Gehrig’s disease, according to a study published online March 24 in Nature Neuroscience, titled “Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.” Lou Gehrig’s…